Literature DB >> 25755507

A case of cutaneous reaction with tenofovir disoproxil fumarate.

Pankaj Jain1.   

Abstract

Hypersensitivity reaction to tenofovir consisting of maculopapular rash on the face, extremities and trunk has been reported in HIV patients. We report the first case in a hepatitis B patient.

Entities:  

Keywords:  HBV, hepadnaviruses; HIV, Human immunodeficiency virus; cutaneous rash; hepatitis B; tenofovir

Year:  2013        PMID： 25755507      PMCID： PMC3940554          DOI： 10.1016/j.jceh.2013.02.020

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


  4 in total

1.  Tenofovir treatment in patients with lamivudine-resistant hepatitis B mutants strongly affects viral replication.

Authors:  Florian van Bömmel; Thomas Wünsche; Dirk Schürmann; Thomas Berg
Journal:  Hepatology       Date:  2002-08       Impact factor: 17.425

2.  Lichenoid drug eruption to tenofovir in an HIV/hepatitis B virus co-infected patient.

Authors:  Ian J Woolley; Alastair J Veitch; Chanad S Harangozo; Mignon Moyle; Tony M Korman
Journal:  AIDS       Date:  2004-09-03       Impact factor: 4.177

3.  The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.

Authors:  Mark R Nelson; Christine Katlama; Julio S Montaner; David A Cooper; Brian Gazzard; Bonaventura Clotet; Adriano Lazzarin; Knud Schewe; Joep Lange; Christina Wyatt; Sue Curtis; Shan-Shan Chen; Stephen Smith; Norbert Bischofberger; James F Rooney
Journal:  AIDS       Date:  2007-06-19       Impact factor: 4.177

4.  Cutaneous reactions with tenofovir disoproxil fumarate: a report of nine cases.

Authors:  Staci M Lockhart; R Chris Rathbun; Johnny R Stephens; Damon L Baker; Douglas A Drevets; Ronald A Greenfield; Michelle R Salvaggio; Simi Vincent
Journal:  AIDS       Date:  2007-06-19       Impact factor: 4.177
  4 in total
  1 in total

1.  Comparison of Tenofovir Disoproxil Fumarate and Entecavir in the Prophylaxis of HBV Reactivation.

Authors:  Bilal Toka; Aydin Seref Koksal; Ahmet Tarik Eminler; Mukaddes Tozlu; Mustafa Ihsan Uslan; Erkan Parlak
Journal:  Dig Dis Sci       Date:  2020-07-29       Impact factor: 3.199
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.